After 5 years and 2 clinical trials, Patient #1 stops cancer treatment: A clinical trial success story for Merck and the industry
The article is great unsolicited PR for Merck. This is a patient testimonial that can be transferred to video. This is a knowledgeable and engaged patient who can inform and provide reassurance to other patients considering clinical trial participation.
The article demonstrates the hard choice about ending treatment, but how the decision is made easier knowing that there is a safety-net of ongoing monitoring by a trusted clinical trial team; a team that has delivered 75 infusions to this patient alone.
Since patients resonate with other patients, I hope that Merck will consider involving this patients in its patient engagement strategies ... Let us know if we can help!
SVP, Business Development at BioFlorida, Inc.
7yexcellent share Liz Moench. Very few of the original check point inhibitor patients are still here to tell their story.